Goldman Sachs Knock-Out DVA/ DE000GG62167 /
06/06/2024 10:24:29 | Chg.-0.01 | Bid15:24:23 | Ask15:24:23 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.25EUR | -0.79% | 1.23 Bid Size: 3,000 |
1.28 Ask Size: 2,000 |
DaVita Inc | 158.4551 USD | 31/12/2078 | Put |
GlobeNewswire
26/04
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
17/11/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
15/08/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
21/03/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
07/03/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
10/02/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
07/10/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
01/10/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
GlobeNewswire
09/09/2021
ACTION BEHAVIOR CENTERS HIRES NEW GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
GlobeNewswire
09/09/2021
Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development